Free meds could boost quit rates in stroke survivors

NCT ID NCT00962988

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This trial tests whether giving stroke or TIA survivors free smoking-cessation medications (like nicotine patches, bupropion, or varenicline) for 12 weeks helps them quit smoking more effectively than just giving a prescription. The study will compare quit rates and cost-effectiveness between the two approaches. Participants are daily smokers who have had a stroke or TIA and are willing to set a quit date.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Free smoking cessation pharmacotherapy (nicotine patch, bupropion, or varenicline)
What this could lead to
If effective, providing free cessation medications could significantly increase quit rates among stroke survivors, reducing their risk of future strokes and improving long-term health.
What could go wrong
The trial is relatively small and focuses on a specific high-risk group, so results may not apply to all smokers. Also, quitting smoking is difficult, and even with free medication, many participants may relapse.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CEREBROVASCULAR DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hamilton Health Sciences -Stroke Prevention Clinic

    Hamilton, Ontario, L8L 2X2, Canada

  • The Ottawa Hospital - Stroke Prevention Clinic

    Ottawa, Ontario, K1Y 4E9, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.